[go: up one dir, main page]

NO881574L - Fremgangsmaate for fremstilling av terapeutisk virksomme sulfonyldecahydro-8h-isokino-(2,1-g)(1,6)-nafthyridiner og optiske isomerer derav. - Google Patents

Fremgangsmaate for fremstilling av terapeutisk virksomme sulfonyldecahydro-8h-isokino-(2,1-g)(1,6)-nafthyridiner og optiske isomerer derav.

Info

Publication number
NO881574L
NO881574L NO881574A NO881574A NO881574L NO 881574 L NO881574 L NO 881574L NO 881574 A NO881574 A NO 881574A NO 881574 A NO881574 A NO 881574A NO 881574 L NO881574 L NO 881574L
Authority
NO
Norway
Prior art keywords
sulphonyldecahydro
naphythridines
isokino
procedure
preparation
Prior art date
Application number
NO881574A
Other languages
English (en)
Other versions
NO170805C (no
NO881574D0 (no
NO170805B (no
Inventor
Robin D Clark
Original Assignee
Syntex Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Syntex Inc filed Critical Syntex Inc
Publication of NO881574D0 publication Critical patent/NO881574D0/no
Publication of NO881574L publication Critical patent/NO881574L/no
Publication of NO170805B publication Critical patent/NO170805B/no
Publication of NO170805C publication Critical patent/NO170805C/no

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D471/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/12Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains three hetero rings
    • C07D471/14Ortho-condensed systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/12Antidiarrhoeals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00Drugs for disorders of the urinary system
    • A61P13/02Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00Drugs for genital or sexual disorders; Contraceptives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/02Drugs for disorders of the nervous system for peripheral neuropathies
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/20Hypnotics; Sedatives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/24Antidepressants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/26Psychostimulants, e.g. nicotine, cocaine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00Drugs for disorders of the senses
    • A61P27/02Ophthalmic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/04Anorexiants; Antiobesity agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/08Drugs for disorders of the metabolism for glucose homeostasis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/02Non-specific cardiovascular stimulants, e.g. drugs for syncope, antihypotensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Diabetes (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Hematology (AREA)
  • Psychiatry (AREA)
  • Endocrinology (AREA)
  • Obesity (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Child & Adolescent Psychology (AREA)
  • Emergency Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Anesthesiology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Reproductive Health (AREA)
  • Pain & Pain Management (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Compounds Of Unknown Constitution (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
NO881574A 1987-04-13 1988-04-12 Analogifremgangsmaate for fremstilling av terapeutisk virksomme sulfonyldecahydro-8h-isokino-(2,1-g)-(1,6)-nafthyridiner og optiske isomerer derav NO170805C (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US07/037,320 US4791108A (en) 1987-04-13 1987-04-13 Sulfonyl-decahydro-8H-isoquino[2,1-G][1,6]-naphthyridines and related compounds useful as α2 -blockers

Publications (4)

Publication Number Publication Date
NO881574D0 NO881574D0 (no) 1988-04-12
NO881574L true NO881574L (no) 1988-10-14
NO170805B NO170805B (no) 1992-08-31
NO170805C NO170805C (no) 1992-12-09

Family

ID=21893706

Family Applications (1)

Application Number Title Priority Date Filing Date
NO881574A NO170805C (no) 1987-04-13 1988-04-12 Analogifremgangsmaate for fremstilling av terapeutisk virksomme sulfonyldecahydro-8h-isokino-(2,1-g)-(1,6)-nafthyridiner og optiske isomerer derav

Country Status (20)

Country Link
US (1) US4791108A (no)
EP (1) EP0288196B1 (no)
JP (1) JP2527784B2 (no)
KR (1) KR960007864B1 (no)
AT (1) ATE92066T1 (no)
AU (1) AU613610B2 (no)
CA (1) CA1331459C (no)
DE (1) DE3882571T2 (no)
DK (2) DK171106B1 (no)
ES (1) ES2058264T3 (no)
FI (1) FI88162C (no)
HU (2) HU199469B (no)
IE (1) IE60624B1 (no)
IL (1) IL86039A (no)
MX (1) MX11083A (no)
NO (1) NO170805C (no)
NZ (1) NZ224221A (no)
PH (1) PH25961A (no)
PT (1) PT87219B (no)
ZA (1) ZA882562B (no)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4956365A (en) * 1987-04-13 1990-09-11 Syntex (U.S.A.) Inc. Decahydro-8H-isoquino(2,1-g)(1,6)naphthyridine derivatives and related compounds
US4886798A (en) * 1987-04-13 1989-12-12 Syntex (U.S.A.) Inc. Optical isomers of sulfonyldecahydro-8H-isoquino-(2,1-G)(1,6) naphthyridines and related compounds useful as α2 -blockers
US4960891A (en) * 1987-04-13 1990-10-02 Syntex (U.S.A.) Inc. Process for the preparation of decahydro-8H-isoquino[2,1-g][1,6]naphthyridine derivatives
GB9012469D0 (en) * 1990-06-05 1990-07-25 Glaxo Group Ltd Medicaments
US5231181A (en) * 1991-03-21 1993-07-27 Syntex (U.S.A.) Inc. Process for the preparation of (8as,12as,13as)-decahydroisoquino ((2,1-g) (1,6)-naphthyridin-8-one derivatives
CA2074038A1 (en) * 1991-07-17 1993-01-18 Robin D. Clark Decahydro-8h-isoquino[2,1-g][1,6]naphthyridine and decahydrobenzo[a] pyrrol[2,3-e]quinolizine derivatives
US5229387A (en) * 1991-09-20 1993-07-20 Syntex (U.S.A.) Inc. Decahydro-8H-isoquino[2,1-g][1,6]naphthyridine and decahydrobenzo[a]pyrrolo [2,3-e]quinolizine derivatives
EP1483231A1 (de) * 2002-03-04 2004-12-08 Boehringer Ingelheim Pharma GmbH & Co.KG Neue salmeterol-zimtsäuresalze, verfahren zu deren herstellung und deren verwendung als arzneimittel
CN103387583B (zh) * 2012-05-09 2018-04-13 中国科学院上海药物研究所 二芳基并[a,g]喹嗪类化合物、其制备方法、药物组合物及其应用

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3953598A (en) * 1972-09-08 1976-04-27 The Upjohn Company Compounds, compositions and methods of use
GB1513824A (en) * 1975-05-22 1978-06-14 Wyeth John & Brother Ltd 1,3,4,6,7,11b-hexahydro-2h-benzo(a)quinolizine derivative
US4353911A (en) * 1979-07-20 1982-10-12 Andre Buzas Indolo(2,3-a)quinolizidines, useful in increasing femoral and vertebral blood flow
CH645653A5 (de) * 1980-08-01 1984-10-15 Ciba Geigy Ag Quaternaere, copolymere, hochmolekulare ammoniumsalze auf acrylbasis, deren herstellung und verwendung als aktive komponente in kosmetischen mitteln.
US4454139A (en) * 1980-08-28 1984-06-12 John Wyeth & Brother, Limited α2 -Adrenoceptor antagonistic benzoquinolizines
GB8302499D0 (en) * 1983-01-29 1983-03-02 Wyeth John & Brother Ltd Benzoquinolizines
US4690928A (en) * 1984-02-02 1987-09-01 Merck & Co., Inc. Substituted hexahydro arylquinolizines as α2 blockers
US4673680A (en) * 1985-09-18 1987-06-16 Pendleton Robert G α2 -adrenergic receptor antagonists as modifiers of gastrointestinal motility

Also Published As

Publication number Publication date
EP0288196B1 (en) 1993-07-28
AU613610B2 (en) 1991-08-08
ZA882562B (en) 1989-12-27
PH25961A (en) 1992-01-13
ES2058264T3 (es) 1994-11-01
PT87219B (pt) 1992-12-31
JP2527784B2 (ja) 1996-08-28
DK84693A (da) 1993-07-15
ATE92066T1 (de) 1993-08-15
DK84693D0 (da) 1993-07-15
PT87219A (pt) 1988-05-01
IL86039A (en) 1993-05-13
NO170805C (no) 1992-12-09
KR960007864B1 (ko) 1996-06-13
DK171106B1 (da) 1996-06-10
DK199388A (da) 1988-10-14
FI88162B (fi) 1992-12-31
DE3882571D1 (de) 1993-09-02
FI88162C (fi) 1993-04-13
DK199388D0 (da) 1988-04-12
HU210349A9 (en) 1995-03-28
IE60624B1 (en) 1994-07-27
DE3882571T2 (de) 1994-01-20
IE881097L (en) 1988-10-13
CA1331459C (en) 1994-08-16
FI881687A0 (fi) 1988-04-12
EP0288196A1 (en) 1988-10-26
AU1450288A (en) 1988-10-13
HU199469B (en) 1990-02-28
IL86039A0 (en) 1988-09-30
FI881687A (fi) 1988-10-14
KR880012601A (ko) 1988-11-28
NO881574D0 (no) 1988-04-12
MX11083A (es) 1993-04-01
NZ224221A (en) 1990-07-26
JPS63277679A (ja) 1988-11-15
US4791108A (en) 1988-12-13
NO170805B (no) 1992-08-31
HUT47107A (en) 1989-01-30

Similar Documents

Publication Publication Date Title
NO164093C (no) Pyridinoksyd-mellomprodukter og fremgangsmaate for deres fremstilling.
NO892058D0 (no) Fremgangsnaate for fremstilling av terapeutisk aktive benzamider.
NO881574D0 (no) Fremgangsmaate for fremstilling av terapeutisk virksomme sulfonyldecahydro-8h-isokino-(2,1-g)(1,6)-nafthyridiner og optiske isomerer derav.
DK196688A (da) Bicykliske forbindelser og fremgangsmaade til fremstilling deraf
NO861244L (no) Fremgangsmaate ved fremstilling av nye therapeutisk aktive (4.2.01)-bicyclooctanderivater.
ATE98961T1 (de) 1,8-benzonaphthyridinderivate und ihre herstellung.
ES2120483T3 (es) Alcoholes benzilo y benzhidrilo.
FI883507A0 (fi) Naftotiazepinderivat och deras framstaellning.
EP0364254A3 (en) Decahydro-8H-isoquino[2,1-g][1,6]naphthyridine derivatives and related compounds
ES536139A0 (es) Procedimiento para la preparacion de quinolinonas-4
ES536140A0 (es) Procedimiento para la preparacion de quinolinonas-4